National Institute of Allergy and Infectious Diseases; Notice of Closed Meeting, 63808-63809 [2015-26719]

Download as PDF 63808 Federal Register / Vol. 80, No. 203 / Wednesday, October 21, 2015 / Notices Place: National Cancer Institute Shady Grove, 9609 Medical Center Drive, Room 7W264, Rockville, MD 20850 (Telephone Conference Call). Contact Person: Reed Graves, Ph.D., Scientific Review Officer, Research Technology and Contract Review Branch, Division of Extramural Activities, National Cancer Institute, 9609 Medical Center Drive, Room 7W264, Bethesda, MD 20892–9750, 240–276–6384, gravesr@mail.nih.gov. Name of Committee: National Cancer Institute Special Emphasis Panel; Cancer Biomarker Development and Validation. Date: December 2, 2015. Time: 11:00 a.m. to 3:00 p.m. Agenda: To review and evaluate grant applications. Place: National Cancer Institute Shady Grove, 9609 Medical Center Drive, Room 4W034, Rockville, MD 20850 (Telephone Conference Call). Contact Person: Jeffrey E. DeClue, Ph.D., Scientific Review Officer, Research Technology and Contract Review Branch, Division of Extramural Activities, National Cancer Institute, NIH, 9609 Medical Center Drive, Room 7W238, Bethesda, MD 20892– 9750, 240–276–6371, decluej@mail.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.392, Cancer Construction; 93.393, Cancer Cause and Prevention Research; 93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer Control, National Institutes of Health, HHS) Dated: October 16, 2015. Melanie J. Gray, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2015–26721 Filed 10–20–15; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health tkelley on DSK3SPTVN1PROD with NOTICES Center for Scientific Review; Notice of Closed Meetings Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. VerDate Sep<11>2014 22:39 Oct 20, 2015 Jkt 238001 Name of Committee: Center for Scientific Review Special Emphasis Panel, Small Business: Non HIV Microbial Vaccines and Countermeasures. Date: November 12, 2015. Time: 8:00 a.m. to 6:30 p.m. Agenda: To review and evaluate grant applications. Place: Bethesda North Marriott Hotel & Conference Center, Montgomery County Conference Center Facility, 5701 Marinelli Road, North Bethesda, MD 20852. Contact Person: Andrea Keane-Myers, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 4218, Bethesda, MD 20892, 301–435–1221, andrea.keane-myers@nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel, Small Business: Radiation Therapy and Biology. Date: November 12–13, 2015. Time: 9:00 a.m. to 11:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892, (Virtual Meeting). Contact Person: Bo Hong, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 6194, MSC 7804, Bethesda, MD 20892, 301–996–6208, hongb@csr.nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel, Small Business PAR Panel: Safe and Effective Instruments and Devices for Use in Neonatal and Pediatric Care Settings. Date: November 12, 2015. Time: 11:00 a.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892, (Virtual Meeting). Contact Person: John Firrell, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 5118, MSC 7854, Bethesda, MD 20892, 301–435– 2598, firrellj@csr.nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel, Small Business: Non-HIV Infectious Diseases Therapeutics. Date: November 12, 2015. Time: 1:00 p.m. to 4:00 p.m. Agenda: To review and evaluate grant applications. Place: Hilton Garden Inn Bethesda, 7301 Waverly Street, Bethesda, MD 20814. Contact Person: Gagan Pandya, Ph.D., Scientific Review Officer, National Institutes of Health, Center for Scientific Review, 6701 Rockledge Drive, Room 3200, MSC 7808, Bethesda, MD 20892, 301–435–1167, pandyaga@mai.nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel, RFA–OD– 15–004—Tobacco Regulatory Science Small Grant Program for New Investigators (R03). Date: November 16, 2015. Time: 8:00 a.m. to 6:00 p.m. Agenda: To review and evaluate grant applications. PO 00000 Frm 00072 Fmt 4703 Sfmt 4703 Place: Bethesda Marriott, 5151 Pooks Hill Road, Bethesda, MD 20814. Contact Person: Lawrence Ka-Yun Ng, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 6152, MSC 7804, Bethesda, MD 20892, 301–435– 1719, ngkl@csr.nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel, PAR–14– 080 International Research in Infectious Diseases including AIDS (IRIDA). Date: November 16, 2015. Time: 8:00 a.m. to 6:00 p.m. Agenda: To review and evaluate grant applications. Place: Embassy Suites Hotel, Chevy Chase Pavilion, 4300 Military Road NW., Washington, DC 20015. Contact Person: Soheyla Saadi, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 3211, MSC 7808, Bethesda, MD 20892, 301–435– 0903, saadisoh@csr.nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel, Member Conflict: Pathogenic Eukaryotes and Vectors. Date: November 16, 2015. Time: 10:00 a.m. to 6:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892. Contact Person: John C Pugh, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 3114, MSC 7808, Bethesda, MD 20892, (301) 435– 2398, pughjohn@csr.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.306, Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333, 93.337, 93.393–93.396, 93.837–93.844, 93.846–93.878, 93.892, 93.893, National Institutes of Health, HHS) Dated: October 15, 2015. Carolyn Baum, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2015–26630 Filed 10–20–15; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute of Allergy and Infectious Diseases; Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), title 5 U.S.C., as amended. The grant applications and the discussions could disclose E:\FR\FM\21OCN1.SGM 21OCN1 Federal Register / Vol. 80, No. 203 / Wednesday, October 21, 2015 / Notices confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute of Allergy and Infectious Diseases Special Emphasis Panel; Limited Competitions: National Biocontainment Laboratories (NBLs) Operations Support (UC7). Date: November 20, 2015. Time: 12:00 p.m. to 4:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Room 3G61, 5601 Fishers Lane, Rockville, MD 20892, (Telephone Conference Call). Contact Person: Travis J Taylor, Ph.D., Scientific Review Program, Division of Extramural Activities, Room 3G62B, 5601 Fishers Lane, MSC 9823, Bethesda, MD 20892–9823, (240) 669–5082, Travis.Taylor@ nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.855, Allergy, Immunology, and Transplantation Research; 93.856, Microbiology and Infectious Diseases Research, National Institutes of Health, HHS) Dated: October 16, 2015. Natasha Copeland, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2015–26719 Filed 10–20–15; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health tkelley on DSK3SPTVN1PROD with NOTICES National Institute on Aging; Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute on Aging Special Emphasis Panel; Sex Difference in Health. Date: November 19, 2015. Time: 10:00 a.m. to 2:00 p.m. Agenda: To review and evaluate grant applications. VerDate Sep<11>2014 22:39 Oct 20, 2015 Jkt 238001 Place: National Institute on Aging, Gateway Building, Rm 2C212, 7201 Wisconsin Avenue, Bethesda, MD 20892, (Telephone Conference Call). Contact Person: Kimberly Firth, Ph.D., National Institutes of Health, National Institute on Aging, Gateway Building, 7201 Wisconsin Avenue, Suite 2C212, Bethesda, MD 20892, 301–402–7702, firthkm@ mail.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.866, Aging Research, National Institutes of Health, HHS) 63809 John-Sowah, M.D., MPH, Medical Officer, (email: john-sowahj@ nhlbi.nih.gov, 301–496–1051); Ornela Rutagarama, B.S., (email: rutagaramaom@nhlbi.nih.gov, 301–496– 1051), National Heart, Lung, and Blood Institute, National Institutes of Health. SUPPLEMENTARY INFORMATION: Sickle cell disease is the most common genetic disorder in the United States. About 100,000 Americans are thought to be living with SCD, and each year another Dated: October 16, 2015. 1,000 babies are born with the disease. Melanie J. Gray, Sickle cell disease is an inherited Program Analyst, Office of Federal Advisory disease that results in abnormal Committee Policy. hemoglobin, the protein in human red [FR Doc. 2015–26720 Filed 10–20–15; 8:45 am] blood cells that carries oxygen to all tissues in the body. Hemoglobin is BILLING CODE 4140–01–P essential for life. A specific single mutation in the gene (DNA) for DEPARTMENT OF HEALTH AND hemoglobin, when inherited from both HUMAN SERVICES parents, causes SCD. The sickle hemoglobin distorts the shape of the red National Institutes of Health blood cell into a ‘sickle’ or crescent moon shape that flows poorly through Announcement of Requirements and small blood vessels. This can cause Registration for the National Heart, problems in virtually any organ by Lung, and Blood Institute ‘‘Novel, reducing the delivery of oxygen and Innovative Tools To Increase Public inflaming the surrounding tissue. These Awareness and Knowledge of Sickle abnormal sickle cells usually die after Cell Disease Undergraduate only about 10 to 20 days (as compared Challenge’’ to normal red blood cells that live about 120 days). Over time, organ damage Authority: 15 U.S.C. 3719. occurs, possibly resulting in a stroke in SUMMARY: The National Heart, Lung, and the brain, kidney damage, or Blood Institute (NHBLI), a component of complications in other organ systems. the National Institutes of Health (NIH) SCD also causes significant pain in the announces the ‘‘Novel, Innovative Tools affected tissues. This pain, which can to Increase Public Awareness and begin in childhood, often escalates as Knowledge of Sickle Cell Disease adulthood approaches, severely Undergraduate Challenge’’ to help affecting the quality of life of address the lack of awareness about individuals with SCD. Sickle cell sickle cell disease and its associated disease not only affects the individual complications and to improve but also his or her family and successful implementation of effective communities. interventions for sickle cell disease There is a lack of awareness about (SCD) in real world settings. In addition, SCD and its associated complications by directing the Challenge at among the general public and affected undergraduate students, the Challenge communities. This unawareness can also aims to advance the field of contribute to the stigma associated with implementation science through SCD, the lack of understanding of how research training, mentoring, and the disease affects individuals and highlighting the contributions of a new families’ daily lives, and to less than generation of undergraduate researchers optimal care experienced by many using a systems science approach to patients. To help address this problem, address multi-faceted problems. the NHLBI is launching the ‘‘Novel, DATES: The Challenge begins October Innovative Tools to Increase Public 21, 2015. Submission Period: November Awareness and Knowledge of Sickle 30, 2015 to March 7, 2016, 11:59 p.m. Cell Disease Undergraduate Challenge’’ PDT, Judging Period: March 14, 2016 to (the ‘‘Challenge’’) to incentivize the March 25, 2016, Winners Notified by development of innovative information email: April 5, 2016, Winners dissemination tools that may be used to Announced: April 19, 2016. (i) increase the general public’s awareness of SCD; (ii) provide FOR FURTHER INFORMATION CONTACT: information on SCD and its Helena O. Mishoe, Ph.D., MPH, Associate Director for Research Training complications to individuals, caregivers, families, and communities affected by and Diversity, (email: mishoeh@ SCD in an easily comprehensible nhlbi.nih.gov, 301–451–5081); Joylene PO 00000 Frm 00073 Fmt 4703 Sfmt 4703 E:\FR\FM\21OCN1.SGM 21OCN1

Agencies

[Federal Register Volume 80, Number 203 (Wednesday, October 21, 2015)]
[Notices]
[Pages 63808-63809]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2015-26719]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Allergy and Infectious Diseases; Notice of 
Closed Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. App.), notice is hereby given of the following 
meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose

[[Page 63809]]

confidential trade secrets or commercial property such as patentable 
material, and personal information concerning individuals associated 
with the grant applications, the disclosure of which would constitute a 
clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute of Allergy and Infectious 
Diseases Special Emphasis Panel; Limited Competitions: National 
Biocontainment Laboratories (NBLs) Operations Support (UC7).
    Date: November 20, 2015.
    Time: 12:00 p.m. to 4:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Room 3G61, 5601 Fishers 
Lane, Rockville, MD 20892, (Telephone Conference Call).
    Contact Person: Travis J Taylor, Ph.D., Scientific Review 
Program, Division of Extramural Activities, Room 3G62B, 5601 Fishers 
Lane, MSC 9823, Bethesda, MD 20892-9823, (240) 669-5082, 
Travis.Taylor@nih.gov.

(Catalogue of Federal Domestic Assistance Program Nos. 93.855, 
Allergy, Immunology, and Transplantation Research; 93.856, 
Microbiology and Infectious Diseases Research, National Institutes 
of Health, HHS)

    Dated: October 16, 2015.
Natasha Copeland,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2015-26719 Filed 10-20-15; 8:45 am]
BILLING CODE 4140-01-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.